Vibrio vulnificus hemolysin dilates rat thoracic aorta by activating guanylate cyclase.
Hemolysin produced by Vibrio vulnificus caused hypotension and tachycardia in rats and dilated rat thoracic aorta. Hemolysin-induced vasodilatation of the aorta was not affected by N omega-nitro-L-arginine methyl ester and aminoguanidine, NO synthase inhibitors, whereas the vasodilatation was inhibited by LY 83,583, a guanylate cyclase inhibitor. Hemolysin elevated cGMP levels, and the elevation was abolished by LY 83,583. These results suggest that V. vulnificus hemolysin activates guanylate cyclase independently of NO synthase, and the subsequent increase in cGMP levels results in vasodilatation.
Kook
H
H
Department of Pharmacology, Chonnam University Medical School, Dong-Ku, Kwangiu, Republic of Korea.
Lee
S E
SE
Baik
Y H
YH
Chung
S S
SS
Rhee
J H
JH
D000818:Animals; D001011:Aorta / Q000187:drug effects*; D006152:Cyclic GMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006162:Guanylate Cyclase / Q000187:drug effects*; D006460:Hemolysin Proteins / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D006460:Hemolysin Proteins; D006162:Guanylate Cyclase; D006152:Cyclic GMP